Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University of Manchester | OTHER |
Not provided
Not provided
Not provided
Not provided
To study the effects of organ transplantation and immunosuppression on the human microbiome, and to understand the interlinkage of changes in the microbiome with clinical events surrounding transplantation, and graft and patient clinical outcomes.
This study will involve the collection of oral swabs, saliva, urine and rectal swabs, blood and skin scrapings from patients before and after kidney and pancreas transplantation. At Day 0 and day 1, week 1, and at 3, 6, and 12 months.
These samples will be collected longitudinally over a period of one year after transplantation and will be analysed using 16s rRNA gene sequencing in order to capture the dynamics of the microbiome after exposure to surgery, immunosuppression and the specific medication necessary during the process of transplantation.
Two groups of recipients will be recruited, the first one includes kidney and/or pancreas transplant recipients from both deceased and living donors.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Sample Collection | Other | This study will involve the collection of oral swabs, saliva, urine and faeces samples, blood and skin scrapings from patients before and after kidney and pancreas transplantation at day 0, day 1, week 1 and at 3, 6 and 12 months post-transplant. |
| Measure | Description | Time Frame |
|---|---|---|
| Changes in the Microbiome following transplantation | The tissue samples will be examined to identify any microbial organisms. This process will involve cell identification and quantification using standard biological markers to identify cell types and numbers | 3 years |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Kidney and Transplant Recipients
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Titus Augustine, FRCP | Contact | 0161 2763647 | 63647 | titus.augustine@mft.nhs.uk |
| Angela Dr Summers, PhD | Contact | 01617012066 | 12066 | angela.summers@mft.nhs.uk |
| Name | Affiliation | Role |
|---|---|---|
| Titus Augustine, FRCP | Consultant Transplant Surgeon | Principal Investigator |
| Oana Piscoran, MD | Clinical Research Fellow | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Manchester University NHS Foundationn Trust | Recruiting | Manchester | Greater Manchester | M13 9WL | United Kingdom |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D013048 | Specimen Handling |
| ID | Term |
|---|---|
| D019411 | Clinical Laboratory Techniques |
| D019937 | Diagnostic Techniques and Procedures |
| D003933 | Diagnosis |
| D008919 | Investigative Techniques |
Not provided
Not provided
Not provided
Not provided
Not provided
This study will involve the collection of oral swabs, saliva, urine and faeces samples, blood and skin scrapings from 50 patients (phase 1) and up to 300 patients (phase 2) before (day of arrival in hospital day 0 and after kidney and pancreas transplantation day 1, week 1, 3, 6,12 months.
In addition duodenal fluid from the donor duodenum which is opened at the time of pancreas transplantation will also be taken in theatre for analysis.
Similar samples will be obtained from deceased multi-organ donors who have consent for research.
Similar samples will also be taken from living kidney donors